Despite the bashers and naysayers attacking the 10K, there

New Post Public Reply Private Reply Replies (0) Message Board
Bsav88atty Jetta09 #2735
Despite the bashers and naysayers attacking the 10K, there were many good nuggets to help us project future revenues and profit. Though I have only skimmed the report due to time constraints, based on what I've read so far, ScripsAmerica still has at least seven potential revenue streams (excluding the DOD revs). At least three of these revenue streams will be generating revenues in May -- Main Ave Pharmacy, WholesaleRx, and RapiMeds Hong Kong. Below are my projected May revenues and NET PROFIT for each (yes, I'm predicting the company will turn a profit and prove all the iHub bashers wrong once and for all):

1. Main Ave Pharmacy - $750,000 ($353,400 to SCRC per disclosure in today's 10K -- $750K Xs 97% Xs 20% estimated sales commission based on industry norms Xs 30% for all Main Ave expenses identified in the agreement that Flyers posted on iHub (thanks, Flyers for posting details, very helpful!) - minus $54K monthly payment to Mr. Fox based on $30 Xs 250 scripts in April -- I do not know how much to include for the "Finance Fee" that is to be paid to SCRC per the agreement, so I will ignore it to be conservative. I understand that it in the compounding pharmacy industry, the profit margins are "extremely favorable" per the core's research and the company's Q&A. So the 70% profit margin that I have assumed here, in my humble opinion, is conservative.)

2. WholesaleRx - $400,000 ($56,000 - 70% gross margin, 20% of gross margin to SCRC -- This is based on prior filings and appears to be pure profit. I was slightly disappointed the company did not make the last payment of $125K.)

3. PIMD - $0 (unfortunately, this promising revenue stream has been quite the disappointment -- despite that SCRC is entitled to 90% of revenues, unfortunately, it is earning $0 per the 10K; this was my biggest disappointment from the 10K, hopefully, the company can get moving with this in June as stated in the 10K.)

4. RapiMed Hong Kong -$200,000 ($200,000 to SCRC, assumes no more orders in May; I will assume 30% profit margin, so $60,000 to the bottom line. This is another revenue stream that has been much slower to develop than initially anticipated. Perhaps it will ignite in 2H FY14.)

5. RapiMed Mainland China - $0 (product approval possibly as early as June, same comments as Hong Kong)

6. RapiMed Canada - $0 (no updates, probably nothing until the second half of 2014)

7. RapiMed US - $0 (not my favorite potential stream of revenue)

An eighth potential revenue stream is the Global Pharma Hub, but I'll ignore that one as well.

So in May, excluding the DOD revenues and the "financing fees" from Main Ave, I am projecting revenues of $609,000 to SCRC and $469,400 of gross profit. I'll further assume $200K for SG&A, which translates to about $269,400 in NET PROFIT. Assuming no further increases, my net profit/earnings estimate would equate to $3,232,800 through April 30, 2015. I will further assume the total shares outstanding increases to 150,000,000, so eps of $0.02, and a PE of 20 (which is uber conservative for such explosive growth). If I am correct, May's earnings would support a pps of at least $0.40. I do not, however, expect the status quo. I expect much more growth.

Indeed, I believe May will be the tip of the iceberg as Scrips continues to grow and fill in all seven of its potential revenue streams (again, excluding the DOD revenues, Main Ave "financing fee", and Global Pharma Hub). For example, if Scrips was able to grow only the Main Ave Pharmacy monthly revenues to $2,000,000 based on 700 scripts (as the Atlanta compounding pharmacy monthly revenues that Guts discovered last week), SCRC's monthly revenues would be $1,342,400, its gross profit about $1,202,400, and net profit of about $1M -- or $12M in net profit over 12 months. (This is pre-tax, and I'll have to find the NOL carry forward to determine a more accurate net earnings.) Applying the same numbers as above (e.g., 150M OS, 20 PE), would yield an eps of $0.08 and a corresponding stock price of $1.60.

Remember also that per D44's post this week, that SCRC has only one more toxic note, which it intends to pay off in May, further supporting my opinion that Scrips is very close to being cash flow positive. Despite the ugly 2013 10K, these are exciting times to be a Scrips shareholder. Hang in there everyone, we will soon have ignition and liftoff!

BSAV

ScripsAmerica Inc (SCRC) Stock Research Links

SCRC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 438

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 325

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 365

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 280

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 210

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 261

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 443

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 448

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 349

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading

Top 5 Most Recently Viewed Articles

Comparison of Amazon.com with Leading Retail Industry Peers

Updated Category News Views 395

Understanding Amazon.com in the Retail Market In an ever-evolving business environment, investors must carefully analyze leading companies. This article presents a detailed evaluation of Amazon.com Inc (NASDAQ: AMZN) and its position compared to competitors in the Broadline Retail industry. By investigating vital financial metrics and market dynamics, we aim to offer...

Continue Reading
Legal Triumph Brings Significant Gains for Safe & Green Holdings

Updated Category News Views 156

Significant Legal Victory for Safe & Green Holdings Safe & Green Holdings Corp. (NASDAQ: SGBX), a prominent player in the modular building sector, recently celebrated a notable victory in a legal battle that promises to deliver substantial value to its shareholders. The company secured a favorable judgment against EDI International, PC, and PVE, LLC, in a case overseen by...

Continue Reading
Innovative Risk Measure for Joint Replacement Surgeons

Updated Category News Views 107

New Risk-Adjusted Measure for Orthopaedic Surgery The American Joint Replacement Registry (AJRR) has announced the launch of an innovative risk-adjusted revision rate measure designed to support orthopaedic surgeons in evaluating their outcomes. This measure is now available through the RegistryInsights platform and aims to provide more equitable and valuable feedback...

Continue Reading
Bybit's Innovative Indices Trading Enhances Investor Opportunities

Updated Category News Views 77

Bybit Expands Trading Options for Cryptocurrency Investors Bybit, recognized among the leading cryptocurrency exchanges worldwide, has recently enhanced its MetaTrader 5 (MT5) platform by introducing the capability to trade global indices using USDT. This significant feature offers users a unique opportunity to engage with traditional markets while still functioning...

Continue Reading
Shoe Palace Enhances Growth and Efficiency with Centric PLM

Updated Category News Views 303

Shoe Palace Enhances Growth and Efficiency with Centric PLM Centric PLM centralizes product development, providing a single, actionable source of truth for retailers striving for innovation. Shoe Palace, a respected name in footwear and fashion retail, has taken a significant step forward by adopting Centric Product Lifecycle Management (PLM) software. This transition...

Continue Reading